Stockreport

BIO-key Reports Q3’24 Revenue Rose 18% to $2.1M, Reduced Q3’24 Net Loss, and Improved Cash Position; Hosts Investor Call Tomorrow, Fri. Nov. 15th, 10am ET

BIO-key International, Inc.  (BKYI) 
NASDAQ:AMEX Investor Relations: bio-key.com/investors
PDF HOLMDEL, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Mana [Read more]